These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16343210)

  • 1. Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: a case report.
    Nagai N; Hirata E; Kusuda T; Mukai K; Arihiro K; Ohama K
    Int J Gynecol Cancer; 2005; 15(6):1187-90. PubMed ID: 16343210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Villoglandular papillary adenocarcinoma of the uterine cervix with bulky lymph node metastases.
    Utsugi K; Shimizu Y; Akiyama F; Hasumi K
    Eur J Obstet Gynecol Reprod Biol; 2002 Nov; 105(2):186-8. PubMed ID: 12381485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
    Aoki Y; Sato T; Watanabe M; Sasaki M; Tsuneki I; Tanaka K
    Gynecol Oncol; 2001 Jun; 81(3):496-9. PubMed ID: 11371145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
    Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
    Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix.
    Datta CK
    W V Med J; 1997; 93(4):186-8. PubMed ID: 9274143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant docetaxel combined with cisplatin and followed by radical surgery for the treatment of locally advanced (stage IB2 - IIB) cervical cancer: preliminary results of a single-institution experience.
    Huang X; Lan C; Huang H; Zhang Y; Huang H; Cao X; Huang Y; Guo Y; Wan T; Liu J
    Expert Opin Pharmacother; 2011 Feb; 12(2):165-73. PubMed ID: 21226631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix.
    Utsugi K; Shimizu Y; Akiyama F; Umezawa S; Hasumi K
    Gynecol Oncol; 2004 Jan; 92(1):64-70. PubMed ID: 14751140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Villoglandular papillary adenocarcinoma of the cervix: case report.
    Lakhtakia R; Singh MK; Taneja P; Kapila K; Kumar S
    J Surg Oncol; 2000 Aug; 74(4):297-9. PubMed ID: 10962465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
    Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
    Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?].
    Reed W; Abeler VM; Tropé CG
    Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2569-71. PubMed ID: 8236177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy with cisplatin, aclacinomycin A, and mitomycin C for cervical adenocarcinoma--a preliminary study.
    Saito T; Takehara M; Lee R; Fujimoto T; Nishimura M; Tanaka R; Ito E; Adachi K; Kudo R
    Int J Gynecol Cancer; 2004; 14(3):483-90. PubMed ID: 15228422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results.
    Park DC; Suh MJ; Yeo SG
    Int J Gynecol Cancer; 2009 Jul; 19(5):943-7. PubMed ID: 19574789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Villoglandular papillary adenocarcinoma of the uterine cervix: report of a case.
    Borgo G; Feyles E; Gaglio A; Tagliani L; Andrion A
    Tumori; 1998; 84(6):717-9. PubMed ID: 10080684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial on neoadjuvant intravenous and trans-uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma.
    Tsubamoto H; Maeda H; Kanazawa R; Ito Y; Ohama N; Hori M; Ikeda Y; Kato T; Sakane R; Hirota S
    Gynecol Oncol; 2013 Apr; 129(1):129-34. PubMed ID: 23333929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
    Iwasaka T; Fukuda K; Hara K; Yokoyama M; Nakao Y; Uchiyama M; Sugimori H
    Gynecol Oncol; 1998 Aug; 70(2):236-40. PubMed ID: 9740697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant intra-arterial chemotherapy followed by total laparoscopic radical trachelectomy in stage IB1 cervical cancer.
    Lu Q; Zhang Y; Wang S; Guo S; Guo H; Zhang Z; Liu C
    Fertil Steril; 2014 Mar; 101(3):812-7. PubMed ID: 24439996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
    Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
    Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Three cases of uterine cervical adenocarcinoma successfully treated by neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil)].
    Narimatsu A; Okada O
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):111-4. PubMed ID: 8546460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.